Technegas, a carbon-coated Tc-99m nanoparticulate aerosol invented by Burch at the
Australian National University in 1984, was introduced to the medical community in 1986 …

Technegas was developed in Australia as an imaging radioaerosol in the late 1980s and is
now commercialized by Cyclomedica, Pty Ltd. for diagnosing pulmonary embolism (PE) …

A new Tc-99m labeled carbon particle aerosol (“Technegas”) has been developed for lung
ventilation scanning. This is the first reported clinical study of this agent in the United States …

Pulmonary embolism demands rapid and accurate diagnosis. And ventilation imaging has
greatly improved the diagnostic accuracy of pulmonary embolism in addition to perfusion …

Technegas (Cyclomedica Asia Pacific) is a versatile yet straightforward system for producing
high-quality 99mTc-based ventilation studies using a carbon-based nanoparticle. Because …

Technegas is an ultra‐fine dry dispersion of 99mTc‐labelled carbon with particle size of ap
proximately 0.005 μn. Because of this small size, penetration characteristics are gas‐like …

A ventilation agent that provides good quality lung images, which is cheap, easy to use and
non-toxic, with a low radiation dose, has long been sought. Technegas, an ultrafine aerosol …

Technegas is a carbon-based nanoparticle developed in Australia in 1984 and has been in
widespread clinical use, including SPECT imaging, since 1986. Although 81mKr offers the …

Technegas (TG), an ultrafine dispersion of carbon aggregates labelled with 99mTechnetium
(99mTc), has been recently introduced for clinical imaging of lung ventilation. In 12 selected …

Technegas is a suspension of structured graphite ellipsoids, between 5 and 20 nm in
aerodynamic diameter and labelled, in a carrier gas of argon, with 99 Tc m. Its emergence …